ArticlebioRxiv : the preprint server for biology2025

Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma.

Cheyanne K Shinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.